• HOME
  • RESEARCH
  • TEAM
    • Meet the team
    • World Map
    • Principal Investigator
    • Current members >
      • Christine Ryan
      • Jeremy Zhang
      • Jing Wang
      • Ritu Somayaji
      • Nathalie Javidi-Sharifi
      • Salem Elias
      • Stephanie Chamberlain
      • Stephen Chong
      • Xiao Lv
    • Alumni >
      • Charles Herbaux
      • Fen Zhu
      • Johannes Hildebrand
      • Liam Hackett
      • Mary Collins
      • Rebecca Valentin
      • Simon Husby
      • Stephanie Grabow
      • Timothy Lehmberg
  • PUBLICATIONS
  • MEDIA
    • News highlights
    • Awards and recognitions
    • Video features
  • JOBS
  • SUPPORT US
  • CONTACT
Davids Lab - Translational CLL Research

The Davids Lab
TRANSLATIONAL CLL RESEARCH


Welcome to the Davids Lab!

The last few years have witnessed a transformation in the approach to treating patients with chronic lymphocytic leukemia (CLL). Yet for most patients, the disease remains incurable.  We are a translational research laboratory that studies patient samples from our clinical trials utilizing novel agents that are in development or recently approved.  We focus on interrogating the mitochondrial pathway of apoptosis through BH3 profiling to predict response and resistance to these treatments, with the goal to use this technique to guide therapeutic decisions and develop more effective treatments.

Picture
Picture
 HOME | RESEARCH | PEOPLE | PUBLICATIONS | JOBS | SUPPORT US | NEWS | CONTACT 

©2016 Translational CLL Research at Dana-Farber Cancer Institute